Medicenna Therapeutics
Logotype for Medicenna Therapeutics Corp

Medicenna Therapeutics (MDNA) investor relations material

Medicenna Therapeutics Q3 2026 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Medicenna Therapeutics Corp
Q3 2026 earnings summary13 Feb, 2026

Executive summary

  • Reported updated clinical data for MDNA11 and bizaxofusp, with strong efficacy in multiple solid tumors and recurrent glioblastoma, respectively.

  • Advanced MDNA113 through preclinical studies, targeting a first-in-human trial in H2 2026.

  • Announced changes to the Board of Directors, with two new appointments following a retirement.

Financial highlights

  • Ended the quarter with $10.6 million in cash and cash equivalents, expected to fund operations into Q3 2026.

  • Operating costs for the quarter were $5.6 million, up from $5.1 million year-over-year, mainly due to increased R&D expenses.

  • Net loss for the quarter was $4.4 million ($0.05 per share), an improvement from $5.2 million ($0.07 per share) in the prior year, driven by a gain on derivative warrant liability.

  • R&D expenses rose to $4.1 million from $3.6 million year-over-year, reflecting expanded clinical activities.

  • G&A expenses remained stable at $1.5 million year-over-year.

Outlook and guidance

  • Cash runway projected into Q3 2026 based on current operating plan.

  • Plans to file an IND for MDNA113 and arrange an End of Phase 1 meeting with the FDA for MDNA11 in 2026.

  • Interim data from the NEO-CYT trial and updated ABILITY-1 results expected in H2 2026.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Medicenna Therapeutics earnings date

Logotype for Medicenna Therapeutics Corp
Q4 202626 Jun, 2026
Medicenna Therapeutics
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Medicenna Therapeutics earnings date

Logotype for Medicenna Therapeutics Corp
Q4 202626 Jun, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Medicenna Therapeutics Corp. is a Canada-based clinical-stage biopharmaceutical company focused on the development of novel immunotherapies for cancer and other diseases. The company’s proprietary platforms are designed to create engineered cytokines, including interleukin-based therapies, aimed at enhancing immune system responses against tumors. The company is headquartered in Toronto, Canada, and its shares are listed on both the NASDAQ and the Toronto Stock Exchange.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage